Aggravation of Exercise-Induced Intestinal Injury by Ibuprofen in Athletes
The DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.
Abstract
INTRODUCTION: Nonsteroidal anti-inflammatory drugs are commonly used by athletes to prevent anticipated exercise-induced pain, thereby putatively improving physical performance. However, these drugs may have potentially hazardous effects on the gastrointestinal (GI) mucosa during strenuous physical exercise. The aim of the current study was to determine the effect of oral ibuprofen administration before exercise on GI integrity and barrier function in healthy individuals. METHODS: Nine healthy, trained men were studied on four different occasions: 1) 400 mg ibuprofen twice before cycling, 2) cycling without ibuprofen, 3) 400 mg ibuprofen twice at rest, and 4) rest without ibuprofen intake. To assess small intestinal injury, plasma intestinal fatty acid binding protein (I-FABP) levels were determined, whereas urinary excretion of orally ingested multisugar test probes was measured using liquid chromatography and mass spectrometry to assess GI permeability. RESULTS: Both ibuprofen consumption and cycling resulted in increased I-FABP levels, reflecting small intestinal injury. Levels were higher after cycling with ibuprofen than after cycling without ibuprofen, rest with ibuprofen, or rest without ibuprofen (peak I-FABP, 875 ± 137, 474 ± 74, 507 ± 103, and 352 ± 44 pg·mL, respectively, P < 0.002). In line, small intestinal permeability increased, especially after cycling with ibuprofen (0-2 h urinary lactulose/rhamnose ratio, 0.08 (0.04-0.56) compared with 0.04 (0.00-0.20), 0.05 (0.01-0.07), and 0.01 (0.01-0.03), respectively), reflecting loss of gut barrier integrity. Interestingly, the extent of intestinal injury and barrier dysfunction correlated significantly (RS = 0.56, P < 0.001). CONCLUSION: This is the first study to reveal that ibuprofen aggravates exercise-induced small intestinal injury and induces gut barrier dysfunction in healthy individuals. We conclude that nonsteroidal anti-inflammatory drugs consumption by athletes is not harmless and should be discouraged.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Intestinal permeability: an overview
Bjarnason, I., Macpherson, A., & Hollander, D. (1995) · Gastroenterology · doi:10.1016/0016-5085(95)90708-4 · Cited by 927
Exercise-Induced Splanchnic Hypoperfusion Results in Gut Dysfunction in Healthy Men
van Wijck, K., Lenaerts, K., van Loon, L. J. C., Peters, W. H. M., Buurman, W. A., & Dejong, C. H. C. (2011) · PLoS ONE · doi:10.1371/journal.pone.0022366 · Cited by 359 · cited 4×
“Furthermore, all 15 athletes participating in our previous study had normal hydration status and no detectable kidney damage after completion of the same exercise protocol as applied in the current study (33).”
InfluentialSelf-citationEffects of exercise on mesenteric blood flow in man.
Qamar, M. I., & Read, A. E. (1987) · Gut · doi:10.1136/gut.28.5.583 · Cited by 234 · cited 1×
“The latter is a result of the redistribution of splanchnic blood flow that occurs to secure adequate perfusion of muscles, skin, heart, and lungs after exercise (24,27).”
BackgroundPeters, H. P. F., Bos, M., Seebregts, L., Akkermans, L. M. A., van Berge Henegouwen, G. P., Bol, E., Mosterd, W. L., & de Vries, W. R. (1999) · American Journal of Gastroenterology · doi:10.1111/j.1572-0241.1999.01147.x · Cited by 188 · cited 1×
“Especially, endurance athletes are well acquainted with the occurrence of GI problems during or after exercise (26,31).”
Exercise induces gastric ischemia in healthy volunteers: a tonometry study
Otte, J. A., Oostveen, E., Geelkerken, R. H., Groeneveld, A. B. J., & Kolkman, J. J. (2001) · Journal of Applied Physiology · doi:10.1152/jappl.2001.91.2.866 · Cited by 138 · cited 1×
“The latter is a result of the redistribution of splanchnic blood flow that occurs to secure adequate perfusion of muscles, skin, heart, and lungs after exercise (24,27).”
BackgroundChanges in the Gastrointestinal Mucosa after Long-Distance Running
Øktedalen, O., Lunde, O. C., Opstad, P. K., Aabakken, L., & Kvernebo, K. (1992) · Scandinavian Journal of Gastroenterology · doi:10.3109/00365529209000073 · Cited by 124 · cited 2×
“Endurance athletes have been observed to have significant GI injury after endurance running without using NSAIDs (8,23), and the combination of exercise and NSAIDs may aggravate this intestinal injury.”
Ter Steege, R. W. F., Van Der Palen, J., & Kolkman, J. J. (2008) · Scandinavian Journal of Gastroenterology · doi:10.1080/00365520802321170 · Cited by 111 · cited 1×
“Especially, endurance athletes are well acquainted with the occurrence of GI problems during or after exercise (26,31).”
BackgroundThe role of gastrointestinal endoscopy in long-distance runners with gastrointestinal symptoms
Choi, S. C., Choi, S. J., Kim, J. A., Kim, T. H., Nah, Y.-H., Yazaki, E., & Evans, D. F. (2001) · European Journal of Gastroenterology & Hepatology · doi:10.1097/00042737-200109000-00016 · Cited by 74
García Rodríguez, L. A., González-Pérez, A., Bueno, H., & Hwa, J. (2011) · PLoS ONE · doi:10.1371/journal.pone.0016780 · Cited by 59
Research works printed but not linked: 20
- Alaranta, 2006, Ample use of physician-prescribed medications in Finnish elite athletes., Int J Sports Med, 27, 919, 10.1055/s-2006-923811 · DOI · Paper page
- Allison, 1992, Gastrointestinal damage associated with the use of nonsteroidal antiinflammatory drugs., N Engl J Med, 327, 749, 10.1056/NEJM199209103271101 · DOI · Paper page
- Blikslager, 2008, Life in the gut without oxygen: adaptive mechanisms and inflammatory bowel disease., Gastroenterology, 134, 346, 10.1053/j.gastro.2007.11.049 · DOI
- Blikslager, 2007, Restoration of barrier function in injured intestinal mucosa., Physiol Rev, 87, 545, 10.1152/physrev.00012.2006 · DOI · Paper page
- Crofford, 1997, COX-1 and COX-2 tissue expression: implications and predictions., J Rheumatol Suppl, 49, 15
- Gabriel, 1991, Risk for serious gastrointestinal complications related to use of nonsteroidal anti-inflammatory drugs. A meta-analysis., Ann Intern Med, 115, 787, 10.7326/0003-4819-115-10-787 · DOI · Paper page
- Garcia Rodriguez, 2007, Risk of upper gastrointestinal complications among users of traditional NSAIDs and COXIBs in the general population., Gastroenterology, 132, 498, 10.1053/j.gastro.2006.12.007 · DOI · Paper page
- Garcia Rodriguez, 1994, Risk of upper gastrointestinal bleeding and perforation associated with individual non-steroidal anti-inflammatory drugs., Lancet, 343, 769, 10.1016/S0140-6736(94)91843-0 · DOI · Paper page
- Garcin, 2005, Use of acetaminophen in young subelite athletes., J Sports Med Phys Fitness, 45, 604
- Kuipers, 1985, Variability of aerobic performance in the laboratory and its physiologic correlates., Int J Sports Med, 6, 197, 10.1055/s-2008-1025839 · DOI · Paper page
- Lieberman, 1997, Human intestinal fatty acid binding protein: report of an assay with studies in normal volunteers and intestinal ischemia., Surgery, 121, 335, 10.1016/S0039-6060(97)90363-9 · DOI · Paper page
- Martin, 2001, New issues about nitric oxide and its effects on the gastrointestinal tract., Curr Pharm Des, 7, 881, 10.2174/1381612013397645 · DOI · Paper page
- Matsui, 2011, The pathophysiology of non-steroidal anti-inflammatory drug (NSAID)-induced mucosal injuries in stomach and small intestine., J Clin Biochem Nutr, 48, 107, 10.3164/jcbn.10-79 · DOI · Paper page
- Ng, 2010, NSAID-induced gastrointestinal and cardiovascular injury., Curr Opin Gastroenterol, 26, 611, 10.1097/MOG.0b013e32833e91eb · DOI · Paper page
- Pelsers, 2005, Fatty acid-binding proteins as plasma markers of tissue injury., Clin Chim Acta, 352, 15, 10.1016/j.cccn.2004.09.001 · DOI · Paper page
- Rainsford, 2009, Ibuprofen: pharmacology, efficacy and safety., Inflammopharmacology, 17, 275, 10.1007/s10787-009-0016-x · DOI · Paper page
- Taioli, 2007, Use of permitted drugs in Italian professional soccer players., Br J Sports Med, 41, 439, 10.1136/bjsm.2006.034405 · DOI · Paper page
- Takeuchi, 2010, Roles of COX inhibition in pathogenesis of NSAID-induced small intestinal damage., Clin Chim Acta, 411, 459, 10.1016/j.cca.2009.12.026 · DOI
- Thuyne, 2008, Declared use of medication in sports., Clin J Sport Med, 18, 143, 10.1097/JSM.0b013e318163f220 · DOI
- van Wijck, 2011, Novel analytical approach to a multi-sugar whole gut permeability assay., J Chromatogr B Analyt Technol Biomed Life Sci, 879, 2794, 10.1016/j.jchromb.2011.08.002 · DOI
Cited by
Gastrointestinal Complaints During Exercise: Prevalence, Etiology, and Nutritional Recommendations
de Oliveira, E. P., Burini, R. C., & Jeukendrup, A. (2014) · Sports Medicine · doi:10.1007/s40279-014-0153-2 · Cited by 402
Costa, R. J. S., Snipe, R. M. J., Kitic, C. M., & Gibson, P. R. (2017) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.14157 · Cited by 400
Burd, N. A., Beals, J. W., Martinez, I. G., Salvador, A. F., & Skinner, S. K. (2019) · Sports Medicine · doi:10.1007/s40279-018-1009-y · Cited by 127
Nieman, D. C., Gillitt, N. D., Knab, A. M., Shanely, R. A., Pappan, K. L., Jin, F., & Lila, M. A. (2013) · PLoS ONE · doi:10.1371/journal.pone.0072215 · Cited by 119
Considerations for ultra-endurance activities: part 1- nutrition
Costa, R. J. S., Hoffman, M. D., & Stellingwerff, T. (2019) · Research in Sports Medicine · doi:10.1080/15438627.2018.1502188 · Cited by 83
(2017) · doi:10.1097/mog.0000000000000322 · Cited by 36
Wilson, P. B. (2020) · Journal of Dietary Supplements · doi:10.1080/19390211.2018.1492484 · Cited by 15
“…athletes poses several problems, including the potential suppression of muscle protein and collagen synthesis (Christensen et al. 2011; Mackey 2013), reduction in gastrointestinal integrity (Van Wijck et al. 2012), and increased occurrence of adverse events during competition (K€uster et al. 2013).”
Background
Metadata
- Authors
- VAN WIJCK, K., LENAERTS, K., VAN BIJNEN, A. A., BOONEN, B., VAN LOON, L. J. C., DEJONG, C. H. C., & BUURMAN, W. A.
- Venue
- Medicine & Science in Sports & Exercise
- Published
- 2012-12
- Volume
- 44
- Issue
- 12
- Pages
- 2257-2262
- ISSN
- 0195-9131 (ISSN-L)
- OpenAlex
- W2335562856
- Cited by
- 106
- References
- 9
- FWCI
- 3.51
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.